Key result
Preoperative erythropoietin with iron undergoes Cochrane protocol evaluation for reducing transfusions during non-cardiac surgery.
Why the study?
The efficacy and safety of preoperative erythropoietin with supplemental iron to reduce perioperative allogeneic red blood cell transfusions in preoperatively anaemic non-cardiac surgery patients is uncertain.
Does preoperative erythropoietin with supplemental iron reduce perioperative allogeneic red blood cell transfusions in preoperatively anaemic people undergoing non-cardiac surgery?
Does preoperative erythropoietin with supplemental iron reduce perioperative allogeneic red blood cell transfusions in preoperatively anaemic people undergoing non-cardiac surgery?
Answers are grounded in this paper and cite their sources.
This is a protocol for a Cochrane Review evaluating the efficacy and safety of preoperative erythropoietin and iron supplementation in reducing transfusions for anaemic patients undergoing non-cardiac surgery.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: We aim to evaluate the efficacy and safety of preoperative erythropoietin (rHuEPO) with supplemental iron (parenteral or oral) in reducing perioperative allogeneic red blood cell transfusions in preoperatively anaemic people undergoing non‐cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Kaufner et al. (2016) studied this question. Preoperative erythropoietin with supplemental iron will be evaluated in a Cochrane Review protocol for its efficacy and safety in reducing transfusions during non-cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: